Safe Haven/SafeTech — European Patent Progress Update
As most within our community are aware, our organization is comprised of two entities, Safe Haven and SafeTech. Safe Haven can be easily defined as the business or the forward-facing entity, whereas SafeTech is the development arm and maintains all intellectual property. SafeTech management recently received word as of October 18, 2021 that pending European Patent: EP3654578 METHODS AND SYSTEMS FOR CRYPTOGRAPHIC PRIVATE KEY MANAGEMENT FOR SECURE MULTIPARTY STORAGE AND TRANSFER OF INFORMATION, is now intended to be granted.
November 15, 2019 is listed as the official filing date of the patent that houses 15 separate claims within. If officially granted (pending administrative aspects that must be carried out by SafeTech), SafeTech will have successfully protected multiple aspects of the underlying core development of Safe Haven’s Inheriti and SafeKey platforms.
Patent and claims can be found: https://patents.google.com/patent/EP3654578A1/
What does an approved patent mean for Safe Haven?
Of course, this is significant in that our protocol cannot be replicated — at least not without authorized use and license. Immediately meaning there is an added level of protection in terms of our intellectual property. Without strictly looking at this from a defensive standpoint, it opens the door to improve marketing the underlying, now protected, product. Simply, more eyes can view it from a business-to-business perspective, without SafeTech risking theft of the core.
Furthermore, the patent also acts in a sense to corner the market by leveraging the claims within. As we begin to see more institutional use of private keys and blockchain specific data, protection methods — especially those capable of being ‘quantum proof’ — will be in high demand with limited providers from which to choose from. Safe Haven of course, will be one of the few.
What about the other pending-patents within the United States and China?
These patents are currently making their way through the process within their respective regulatory bodies. A collateral aspect of having an approved patent of the same nature is the ability for patent regulators to use the approved patent as a reference. It is possible that this will assist the other regulatory bodies in adjudicating a decision that is also in our favor, further protecting our core intellectual property — casting a global net.
We will continue to update the community with any progression. We wanted to take a moment to ensure that everyone is with us on this journey and understood the next steps we will take in preserving our future, and protecting yours.
As always, all of us at Safe Haven want to thank our community for your continued support. Be sure to keep up with our official channels!
Find out more about Safe Haven and the range of solutions and products within our ecosystem: https://safehaven.io
Join our Official Telegram Channel: https://t.me/safehavenio
Join our Official Announcements Telegram Channel: https://t.me/safehavenio_announcements